Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Aura Paris

Research site

France 12 Rue Anselme, 93400 St Ouen Sur Seine, France

  • 2 trials recruiting
  • APOL1-mediated kidney disease · Atrial fibrillation · End stage renal disease
  • Adults and children

About Specializations

Aura Paris in St Ouen Sur Seine, France specialises in clinical trials of conditions such as APOL1-mediated kidney disease, Atrial fibrillation, End stage renal disease, Chronic kidney disease, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
12 Rue Anselme93400 St Ouen Sur SeineFrance
Open in maps ↗
Recruiting now
2 trials
Conditions studied
5

More sites in St Ouen Sur SeineFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

APOL1-mediated kidney disease

Recruiting

Study of MZE829 capsules for adults with APOL1 kidney disease and protein in urine

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:MZE829
  • Sponsor:Maze Therapeutics Inc.

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Renal failure

Not recruiting

Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Inaxaplin
  • Sponsor:Vertex Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.